Rapamycin 29-enols
US6677357B2 · kind B2 · utility
84Cited by
20References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2002 |
| Grant date | Jan 13, 2004 |
| Priority date | — |
| Expiry date | Aug 22, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides non-immunosuppressive rapamycin 29-enols, which are useful as neurotrophic agents, in the treatment of solid tumors, and vascular disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.